The results based on survival analysis highlight that the m6Sig score system can effectively predict the prognosis of melanoma patients, and that this score system is strongly associated with TCGA molecular subtypes, genomic alternations, and PD-L1 expression levels. The gene discussed is CD274; the disease is melanoma.